Long-term Effects of Hepatitis B Immunization of Infants in Preventing Liver Cancer

Mei Hwei Chang; San Lin You; Chien Jen Chen; Chun Jen Liu; Ming Wei Lai; Tzee Chung Wu; Shu Fen Wu; Chuan Mo Lee; Sheng Shun Yang; Heng Cheng Chu; Tsang Eng Wang; Bor Wen Chen; Wan Long Chuang; Maw Soan Soon; Ching Yih Lin; Shu Ti Chiou; Hsu Sung Kuo; Ding Shinn Chen; Yao Jong Yang; Gin Ho Lo; Man San Kong; Po Ming Wang; Chi Chieh Yang; Chia Hsiang Chu; Lung Huan Lin; Rong Nan Chien; Tzong Hsi Lee; Kuo Ching Yang; Li Ying Liao; Lein Ray Mo; Jean Dean Liu; Tzeng Huey Yang; Ching Chu Lo; Ming Hung Tsai; Chang Hua Chou; Yeong Shan Cheng

doi:10.1053/j.gastro.2016.05.048

Long-term Effects of Hepatitis B Immunization of Infants in Preventing Liver Cancer

Mei Hwei Chang, San Lin You, Chien Jen Chen, Chun Jen Liu, Ming Wei Lai, Tzee Chung Wu, Shu Fen Wu, Chuan Mo Lee, Sheng Shun Yang, Heng Cheng Chu, Tsang Eng Wang, Bor Wen Chen, Wan Long Chuang, Maw Soan Soon, Ching Yih Lin, Shu Ti Chiou, Hsu Sung Kuo, Ding Shinn Chen, Yao Jong Yang, Gin Ho LoMan San Kong, Po Ming Wang, Chi Chieh Yang, Chia Hsiang Chu, Lung Huan Lin, Rong Nan Chien, Tzong Hsi Lee, Kuo Ching Yang, Li Ying Liao, Lein Ray Mo, Jean Dean Liu, Tzeng Huey Yang, Ching Chu Lo, Ming Hung Tsai, Chang Hua Chou, Yeong Shan Cheng

Research output: Contribution to journal › Article › peer-review

188 Citations (Scopus)

Abstract

Background & Aims The incidence of hepatocellular carcinoma (HCC) increases with age, but protective antibody responses decrease with time after infants are immunized against hepatitis B virus (HBV). We investigated whether immunization of infants against HBV prevents their developing HCC as adults. We also searched for strategies to maximize the cancer-preventive effects. Methods We collected data from 2 Taiwan HCC registry systems on 1509 patients (6–26 years old) diagnosed with HCC from 1983 through 2011. Data on history of HBV immunization and prenatal maternal levels of HBV antigens of all HCC patients born after July 1984 were retrieved from the HBV immunization data bank of the Taiwan Center for Disease Control. We collected data on birth cohort-specific populations (6–26 years old) of Taiwan using the National Household Registry System. Rates of HCC incidence per 10⁵ person-years were derived by dividing the number of patients with HCC by the person-years of the general population. Relative risks (RR) for HCC were estimated by Poisson regression analysis in vaccinated vs unvaccinated birth cohorts. We stratified patients by age group to evaluate the association of birth cohorts and HCC risks. Results Of the 1509 patients with HCC, 1343 were born before, and 166 were born after, the HBV vaccination program began. HCC incidence per 10⁵ person-years was 0.92 in the unvaccinated cohort and 0.23 in the vaccinated birth cohorts. The RRs for HCC in patients 6–9 years old, 10–14 years old, 15–19 years old, and 20–26 years old who were vaccinated vs unvaccinated were 0.26 (95% confidence interval [CI], 0.17–0.40), 0.34 (95% CI, 0.25–0.48), 0.37 (95% CI, 0.25–0.51), and 0.42 (95% CI, 0.32–0.56), respectively. The RR for HCC in 6- to 26-year-olds was lower in the later vs the earlier cohorts (born in 1992–2005 vs 1986–1992; P <.001 and 1986–1992 vs 1984–1986; P < .002). Transmission of HBV from highly infectious mothers and incomplete immunization were associated with development of HCC. Conclusions Based on an analysis of 1509 patients with HCC in Taiwan, immunization of infants against HBV reduces their risk of developing HCC as children and young adults. Improving HBV vaccination strategies and overcoming risk factors could reduce the incidence of liver cancer.

Original language	English
Pages (from-to)	472-480.e1
Journal	Gastroenterology
Volume	151
Issue number	3
DOIs	https://doi.org/10.1053/j.gastro.2016.05.048
Publication status	Published - Sept 1 2016
Externally published	Yes

Keywords

Cancer Prevention
Liver Carcinogenesis
Population Study
Viral Hepatitis

ASJC Scopus subject areas

Gastroenterology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1053/j.gastro.2016.05.048

Cite this

Chang, M. H., You, S. L., Chen, C. J., Liu, C. J., Lai, M. W., Wu, T. C., Wu, S. F., Lee, C. M., Yang, S. S., Chu, H. C., Wang, T. E., Chen, B. W., Chuang, W. L., Soon, M. S., Lin, C. Y., Chiou, S. T., Kuo, H. S., Chen, D. S., Yang, Y. J., ... Cheng, Y. S. (2016). Long-term Effects of Hepatitis B Immunization of Infants in Preventing Liver Cancer. Gastroenterology, 151(3), 472-480.e1. https://doi.org/10.1053/j.gastro.2016.05.048

Chang, MH, You, SL, Chen, CJ, Liu, CJ, Lai, MW, Wu, TC, Wu, SF, Lee, CM, Yang, SS, Chu, HC, Wang, TE, Chen, BW, Chuang, WL, Soon, MS, Lin, CY, Chiou, ST, Kuo, HS, Chen, DS, Yang, YJ, Lo, GH, Kong, MS, Wang, PM, Yang, CC, Chu, CH, Lin, LH, Chien, RN, Lee, TH, Yang, KC, Liao, LY, Mo, LR, Liu, JD, Yang, TH, Lo, CC, Tsai, MH, Chou, CH & Cheng, YS 2016, 'Long-term Effects of Hepatitis B Immunization of Infants in Preventing Liver Cancer', Gastroenterology, vol. 151, no. 3, pp. 472-480.e1. https://doi.org/10.1053/j.gastro.2016.05.048

@article{c640abf802ef477a9e817934c2932771,

title = "Long-term Effects of Hepatitis B Immunization of Infants in Preventing Liver Cancer",

abstract = "Background & Aims The incidence of hepatocellular carcinoma (HCC) increases with age, but protective antibody responses decrease with time after infants are immunized against hepatitis B virus (HBV). We investigated whether immunization of infants against HBV prevents their developing HCC as adults. We also searched for strategies to maximize the cancer-preventive effects. Methods We collected data from 2 Taiwan HCC registry systems on 1509 patients (6–26 years old) diagnosed with HCC from 1983 through 2011. Data on history of HBV immunization and prenatal maternal levels of HBV antigens of all HCC patients born after July 1984 were retrieved from the HBV immunization data bank of the Taiwan Center for Disease Control. We collected data on birth cohort-specific populations (6–26 years old) of Taiwan using the National Household Registry System. Rates of HCC incidence per 105 person-years were derived by dividing the number of patients with HCC by the person-years of the general population. Relative risks (RR) for HCC were estimated by Poisson regression analysis in vaccinated vs unvaccinated birth cohorts. We stratified patients by age group to evaluate the association of birth cohorts and HCC risks. Results Of the 1509 patients with HCC, 1343 were born before, and 166 were born after, the HBV vaccination program began. HCC incidence per 105 person-years was 0.92 in the unvaccinated cohort and 0.23 in the vaccinated birth cohorts. The RRs for HCC in patients 6–9 years old, 10–14 years old, 15–19 years old, and 20–26 years old who were vaccinated vs unvaccinated were 0.26 (95% confidence interval [CI], 0.17–0.40), 0.34 (95% CI, 0.25–0.48), 0.37 (95% CI, 0.25–0.51), and 0.42 (95% CI, 0.32–0.56), respectively. The RR for HCC in 6- to 26-year-olds was lower in the later vs the earlier cohorts (born in 1992–2005 vs 1986–1992; P <.001 and 1986–1992 vs 1984–1986; P < .002). Transmission of HBV from highly infectious mothers and incomplete immunization were associated with development of HCC. Conclusions Based on an analysis of 1509 patients with HCC in Taiwan, immunization of infants against HBV reduces their risk of developing HCC as children and young adults. Improving HBV vaccination strategies and overcoming risk factors could reduce the incidence of liver cancer.",

keywords = "Cancer Prevention, Liver Carcinogenesis, Population Study, Viral Hepatitis",

author = "Chang, {Mei Hwei} and You, {San Lin} and Chen, {Chien Jen} and Liu, {Chun Jen} and Lai, {Ming Wei} and Wu, {Tzee Chung} and Wu, {Shu Fen} and Lee, {Chuan Mo} and Yang, {Sheng Shun} and Chu, {Heng Cheng} and Wang, {Tsang Eng} and Chen, {Bor Wen} and Chuang, {Wan Long} and Soon, {Maw Soan} and Lin, {Ching Yih} and Chiou, {Shu Ti} and Kuo, {Hsu Sung} and Chen, {Ding Shinn} and Yang, {Yao Jong} and Lo, {Gin Ho} and Kong, {Man San} and Wang, {Po Ming} and Yang, {Chi Chieh} and Chu, {Chia Hsiang} and Lin, {Lung Huan} and Chien, {Rong Nan} and Lee, {Tzong Hsi} and Yang, {Kuo Ching} and Liao, {Li Ying} and Mo, {Lein Ray} and Liu, {Jean Dean} and Yang, {Tzeng Huey} and Lo, {Ching Chu} and Tsai, {Ming Hung} and Chou, {Chang Hua} and Cheng, {Yeong Shan}",

note = "Publisher Copyright: {\textcopyright} 2016 AGA Institute",

year = "2016",

month = sep,

day = "1",

doi = "10.1053/j.gastro.2016.05.048",

language = "English",

volume = "151",

pages = "472--480.e1",

journal = "Gastroenterology",

issn = "0016-5085",

publisher = "W.B. Saunders Ltd",

number = "3",

}

TY - JOUR

T1 - Long-term Effects of Hepatitis B Immunization of Infants in Preventing Liver Cancer

AU - Chang, Mei Hwei

AU - You, San Lin

AU - Chen, Chien Jen

AU - Liu, Chun Jen

AU - Lai, Ming Wei

AU - Wu, Tzee Chung

AU - Wu, Shu Fen

AU - Lee, Chuan Mo

AU - Yang, Sheng Shun

AU - Chu, Heng Cheng

AU - Wang, Tsang Eng

AU - Chen, Bor Wen

AU - Chuang, Wan Long

AU - Soon, Maw Soan

AU - Lin, Ching Yih

AU - Chiou, Shu Ti

AU - Kuo, Hsu Sung

AU - Chen, Ding Shinn

AU - Yang, Yao Jong

AU - Lo, Gin Ho

AU - Kong, Man San

AU - Wang, Po Ming

AU - Yang, Chi Chieh

AU - Chu, Chia Hsiang

AU - Lin, Lung Huan

AU - Chien, Rong Nan

AU - Lee, Tzong Hsi

AU - Yang, Kuo Ching

AU - Liao, Li Ying

AU - Mo, Lein Ray

AU - Liu, Jean Dean

AU - Yang, Tzeng Huey

AU - Lo, Ching Chu

AU - Tsai, Ming Hung

AU - Chou, Chang Hua

AU - Cheng, Yeong Shan

PY - 2016/9/1

Y1 - 2016/9/1

N2 - Background & Aims The incidence of hepatocellular carcinoma (HCC) increases with age, but protective antibody responses decrease with time after infants are immunized against hepatitis B virus (HBV). We investigated whether immunization of infants against HBV prevents their developing HCC as adults. We also searched for strategies to maximize the cancer-preventive effects. Methods We collected data from 2 Taiwan HCC registry systems on 1509 patients (6–26 years old) diagnosed with HCC from 1983 through 2011. Data on history of HBV immunization and prenatal maternal levels of HBV antigens of all HCC patients born after July 1984 were retrieved from the HBV immunization data bank of the Taiwan Center for Disease Control. We collected data on birth cohort-specific populations (6–26 years old) of Taiwan using the National Household Registry System. Rates of HCC incidence per 105 person-years were derived by dividing the number of patients with HCC by the person-years of the general population. Relative risks (RR) for HCC were estimated by Poisson regression analysis in vaccinated vs unvaccinated birth cohorts. We stratified patients by age group to evaluate the association of birth cohorts and HCC risks. Results Of the 1509 patients with HCC, 1343 were born before, and 166 were born after, the HBV vaccination program began. HCC incidence per 105 person-years was 0.92 in the unvaccinated cohort and 0.23 in the vaccinated birth cohorts. The RRs for HCC in patients 6–9 years old, 10–14 years old, 15–19 years old, and 20–26 years old who were vaccinated vs unvaccinated were 0.26 (95% confidence interval [CI], 0.17–0.40), 0.34 (95% CI, 0.25–0.48), 0.37 (95% CI, 0.25–0.51), and 0.42 (95% CI, 0.32–0.56), respectively. The RR for HCC in 6- to 26-year-olds was lower in the later vs the earlier cohorts (born in 1992–2005 vs 1986–1992; P <.001 and 1986–1992 vs 1984–1986; P < .002). Transmission of HBV from highly infectious mothers and incomplete immunization were associated with development of HCC. Conclusions Based on an analysis of 1509 patients with HCC in Taiwan, immunization of infants against HBV reduces their risk of developing HCC as children and young adults. Improving HBV vaccination strategies and overcoming risk factors could reduce the incidence of liver cancer.

AB - Background & Aims The incidence of hepatocellular carcinoma (HCC) increases with age, but protective antibody responses decrease with time after infants are immunized against hepatitis B virus (HBV). We investigated whether immunization of infants against HBV prevents their developing HCC as adults. We also searched for strategies to maximize the cancer-preventive effects. Methods We collected data from 2 Taiwan HCC registry systems on 1509 patients (6–26 years old) diagnosed with HCC from 1983 through 2011. Data on history of HBV immunization and prenatal maternal levels of HBV antigens of all HCC patients born after July 1984 were retrieved from the HBV immunization data bank of the Taiwan Center for Disease Control. We collected data on birth cohort-specific populations (6–26 years old) of Taiwan using the National Household Registry System. Rates of HCC incidence per 105 person-years were derived by dividing the number of patients with HCC by the person-years of the general population. Relative risks (RR) for HCC were estimated by Poisson regression analysis in vaccinated vs unvaccinated birth cohorts. We stratified patients by age group to evaluate the association of birth cohorts and HCC risks. Results Of the 1509 patients with HCC, 1343 were born before, and 166 were born after, the HBV vaccination program began. HCC incidence per 105 person-years was 0.92 in the unvaccinated cohort and 0.23 in the vaccinated birth cohorts. The RRs for HCC in patients 6–9 years old, 10–14 years old, 15–19 years old, and 20–26 years old who were vaccinated vs unvaccinated were 0.26 (95% confidence interval [CI], 0.17–0.40), 0.34 (95% CI, 0.25–0.48), 0.37 (95% CI, 0.25–0.51), and 0.42 (95% CI, 0.32–0.56), respectively. The RR for HCC in 6- to 26-year-olds was lower in the later vs the earlier cohorts (born in 1992–2005 vs 1986–1992; P <.001 and 1986–1992 vs 1984–1986; P < .002). Transmission of HBV from highly infectious mothers and incomplete immunization were associated with development of HCC. Conclusions Based on an analysis of 1509 patients with HCC in Taiwan, immunization of infants against HBV reduces their risk of developing HCC as children and young adults. Improving HBV vaccination strategies and overcoming risk factors could reduce the incidence of liver cancer.

KW - Cancer Prevention

KW - Liver Carcinogenesis

KW - Population Study

KW - Viral Hepatitis

UR - http://www.scopus.com/inward/record.url?scp=84979702245&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84979702245&partnerID=8YFLogxK

U2 - 10.1053/j.gastro.2016.05.048

DO - 10.1053/j.gastro.2016.05.048

M3 - Article

C2 - 27269245

AN - SCOPUS:84979702245

SN - 0016-5085

VL - 151

SP - 472-480.e1

JO - Gastroenterology

JF - Gastroenterology

IS - 3

ER -

Long-term Effects of Hepatitis B Immunization of Infants in Preventing Liver Cancer

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this